Search for: "BRECKENRIDGE v. BRECKENRIDGE" Results 41 - 60 of 77
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
25 Apr 2011, 11:30 pm
Breckenridge Pharm., Inc. v. [read post]
5 Nov 2018, 6:41 am by MOTP
The five-lane highway was the busiest street in Breckenridge with a speed limit of forty miles per hour. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
11 Sep 2014, 3:10 am
In the chair is the perspicacious David Rosenberg (Vice President of IP Policy, at GlaxoSmithKline) and, if he supplies some spice, the main courses are furnished by Sir Alasdair Breckenridge (former Chairman of the Medicines and Healthcare Products Regulatory Agency and also of the Committee on Safety of Medicines)  and Peter Feldschreiber (a barrister-physician and a Jolly Good Fellow of the Faculty of Pharmaceutical Medicine). [read post]
1 Sep 2015, 2:27 pm by Mark Jaycox
In fact, STORMBREW’s Breckenridge site was “100% subsidized with CNCI funding. [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
27 Jan 2010, 8:33 am by Steve Hall
"Missouri AG Seeks Execution Dates for Neo-Nazi Mass-murderer, Good Samaritan-killer," is the staff report from today's Kansas City InfoZine.The US Court of Appeals for the Eighth Circuit had put Missouri's death-penalty protocol on hold while it reviewed certain facts in Clemons v. [read post]
19 Oct 2011, 3:30 am by Marie Louise
(IPBiz) US: Patent protection for the BRCA1 gene and genetic diagnostic methods in the USA: AMP v USPTO (JIPLP) US: Marking with an unenforceable patent does not create intent to deceive: Hollander v Hospira (Chicago Intellectual Property Law Blog) US: Regenerative Sciences lawsuit update and FDA’s attempt to broaden the definition of “interstate commerce”: USA v Regenerative Sciences (FDA Law Blog)   Products Embeda (Morphine, Naltrexone) –… [read post]
18 May 2011, 12:33 am by Marie Louise
207/10 Orifarm v Merck and Paranova v Merck Sharp & Dohme (IPKat) EU: European Court of Justice considers embryonic stem cell ban: Oliver Brüstle v Greenpeace eV (Patent Docs) India: Border push in EU FTA to hit pharma exports (GenericsWeb) US: BPAI seeks further briefing on claim encompassing “400 billion oligomers”: Ex parte DeGrado (Patent Docs) US: FDA completes implementation of Affordable Care Act sec. 10609 “generic loophole”… [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]